ストックスクリーナーアプリを入手
108.93
0.92%
0.7099
前日終値:
$108.22
開ける：
$109.24
24時間の取引高:
199.57K
Relative Volume:
0.23
時価総額：
$4.95B
収益：
$1.33B
当期純損益:
$97.31M
株価収益率:
53.62
EPS:
2.0317
ネットキャッシュフロー:
$260.44M
1週間 パフォーマンス:
+20.28%
1か月 パフォーマンス:
+39.89%
6か月 パフォーマンス:
+78.49%
1年 パフォーマンス:
+102.32%
1日の値動き範囲:
$107.00
$109.52
1週間の範囲:
$89.06
$109.56
52週間の値動き範囲:
$47.31
$109.56
Haemonetics Corp Stock (HAE) Company Profile
Compare HAE vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
108.85 | 4.93B | 1.33B | 97.31M | 260.44M | 2.0317 |
ABT
Abbott Laboratories
|
116.25 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.15 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.01 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.70 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.80 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | ダウングレード | Needham | Buy → Hold |
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-08-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 繰り返されました | Barrington Research | Outperform |
| 2025-08-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-06-26 | 開始されました | Robert W. Baird | Outperform |
| 2025-02-07 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 開始されました | JP Morgan | Overweight |
| 2024-11-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 開始されました | CL King | Buy |
| 2024-09-11 | 開始されました | BofA Securities | Neutral |
| 2024-09-10 | 開始されました | BTIG Research | Buy |
| 2024-06-12 | アップグレード | Needham | Hold → Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-01-27 | ダウングレード | Needham | Buy → Hold |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-17 | 再開されました | Raymond James | Outperform |
| 2021-06-17 | 開始されました | Citigroup | Buy |
| 2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 開始されました | Needham | Buy |
| 2019-08-07 | 繰り返されました | Barrington Research | Outperform |
| 2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-08-09 | 繰り返されました | Barrington Research | Outperform |
| 2018-02-07 | 繰り返されました | Barrington Research | Outperform |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
| 2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-08-02 | 繰り返されました | Jefferies | Buy |
| 2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
HAE Maintained by Baird -- Price Target Raised to $119.00 - GuruFocus
Robert W. Baird Issues Positive Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics: Worth Speculating On This Recurring Medtech Plasma Model (NYSE:HAE) - Seeking Alpha
26,280 Shares in Haemonetics Corporation $HAE Acquired by Nierenberg Investment Management Company LLC - MarketBeat
Aurora Investment Counsel Acquires New Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics stock hits 52-week high at 106.64 USD By Investing.com - Investing.com South Africa
HAE Maintains by Barrington Research -- Price Target Raised to $118 - GuruFocus
HAEMONETICS CORP : BARRINGTON RESEARCH RAISES TARGET PRICE TO $118 FROM $95 - Bitget
Haemonetics stock hits 52-week high at 106.64 USD - Investing.com
Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating - marketscreener.com
Haemonetics Shares Hit New 52-Week High: What's Happening? - Sahm
Is Haemonetics’ (HAE) ESOP Shelf Move Reframing Its Balance Between Growth Investment and Shareholder Dilution? - simplywall.st
Haemonetics Corp (HAE) Shares Surge 15.9% -- What GF Score of 85 Tells Investors - GuruFocus
HAE Maintained by BTIG -- Price Target Raised to $110 - GuruFocus
Haemonetics (HAE) Stock Climbs As Analysts Hike Price Targets - StocksToTrade
Form 8K Haemonetics Corp For: 18 August By Investing.com - Investing.com Australia
Haemonetics Jumps as Investors Cheer Raised Fiscal 2027 Outlook - Quiver Quantitative
HAE Looks 23.1% Overvalued on GF Value™ - GuruFocus
Haemonetics stock surges 16% on CSL Plasma supply deal By Investing.com - Investing.com Australia
Haemonetics stock surges 16% on CSL Plasma supply deal - Investing.com
HAE Looks 21.1% Overvalued on GF Value™ as Stock Surges to $104 - GuruFocus
Haemonetics (NYSE:HAE) Reaches New 12-Month High Following Analyst Upgrade - MarketBeat
Haemonetics (NYSE:HAE) Price Target Raised to $110.00 at BTIG Research - MarketBeat
Haemonetics Announces Non-Exclusive Supply Agreement with CSL Plasma for NexSys PCS Devices - Kalkine Media
HAE Looks 5.9% Overvalued on GF Value™ as Supply Deal with CSL P - GuruFocus
Why is Haemonetics stock surging today? - Investing.com
Why is Haemonetics stock surging today? By Investing.com - Investing.com Australia
Haemonetics announces non-exclusive supply agreement with CSL Plasma By Investing.com - Investing.com Australia
Haemonetics rises after supply deal with CSL - seekingalpha.com
Haemonetics announces non-exclusive supply agreement with CSL Plasma - Investing.com
Haemonetics signs non-exclusive U.S. supply deal with CSL Plasma for NexSys PCS devices - TradingView
Rice Hall James & Associates LLC Makes New Investment in Haemonetics Corporation $HAE - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Haemonetics (HAE) Q1 2027 Earnings Call Transcript - AOL.com
Haemonetics (HAE) Stock Could Be 49% Below Fair Value On Raised Guidance - Yahoo Finance
Haemonetics (HAE) Earnings Beat Puts Fair Value Back In Focus - Yahoo Finance
Haemonetics (NYSE:HAE) Shines in Quality Investing Screen - ChartMill
5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call - Yahoo Finance
John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Portfolio Impact - Yahoo Finance
John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Port - GuruFocus
HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up - Yahoo Finance
Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (NYSE:HAE) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Haemonetics Corp (HAE) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
AQR Capital discloses 4.99% Haemonetics Corp (HAE) position in Schedule 13G/A - Stock Titan
Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $95 - Moomoo
Quantinno Capital Management LP Has $1.73 Million Stock Holdings in Haemonetics Corporation $HAE - MarketBeat
Does Strong Q1 Results And VASCADE Data Shift The Bull Case For Haemonetics (HAE)? - simplywall.st
Haemonetics (NYSE:HAE) Sets New 12-Month HighStill a Buy? - MarketBeat
Haemonetics stock hits 52-week high at 88.73 USD By Investing.com - Investing.com South Africa
Haemonetics stock hits 52-week high at 88.73 USD - Investing.com
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
1.36%
大文字化:
|
ボリューム (24 時間):